End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.5 CNY | -1.32% | -5.90% | -32.19% |
Business Summary
Number of employees: 1,962
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Crack, Small Crack
61.1
%
| 728 | 58.6 % | 738 | 61.1 % | +1.38% |
Other Pharmaceutical Products
16.6
%
| 180 | 14.5 % | 201 | 16.6 % | +11.83% |
OEM and Wholesale and Retail Pharmaceuticals
8.6
%
| 152 | 12.3 % | 104 | 8.6 % | -31.50% |
Complete Production Line
6.4
%
| 98 | 7.9 % | 78 | 6.4 % | -20.60% |
Health Product
3.5
%
| 27 | 2.1 % | 42 | 3.5 % | +60.27% |
Real Estate Leasing and Management
3.2
%
| 42 | 3.4 % | 38 | 3.2 % | -9.05% |
Mechanical Parts and Others
0.6
%
| 11 | 0.9 % | 7 | 0.6 % | -34.27% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.6
%
| 1,231 | 99.1 % | 1,205 | 99.6 % | -2.12% |
Overseas
0.4
%
| 12 | 0.9 % | 4 | 0.4 % | -62.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bao Kang Wei
CEO | Chief Executive Officer | 56 | 08/12/19 |
Qing Guo Wang
DFI | Director of Finance/CFO | 49 | 24/08/22 |
Zhi Yong Zheng
BRD | Director/Board Member | 56 | 12/10/17 |
Qiang Lin
BRD | Director/Board Member | 60 | 30/06/04 |
Yi Xi Kuai
BRD | Director/Board Member | 66 | 30/06/04 |
Xin He
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jin Lou
BRD | Director/Board Member | 94 | 12/10/17 |
Bao Kang Wei
CEO | Chief Executive Officer | 56 | 08/12/19 |
Yi Xi Kuai
BRD | Director/Board Member | 66 | 30/06/04 |
Run Xiu Li
BRD | Director/Board Member | 55 | 30/06/04 |
Jian Wei Zhu
BRD | Director/Board Member | 69 | 17/11/20 |
Zhi Yong Zheng
BRD | Director/Board Member | 56 | 12/10/17 |
Wen Jie Ma
BRD | Director/Board Member | 42 | 12/10/17 |
Liu Yang
BRD | Director/Board Member | 39 | 12/10/17 |
Li Li Wang
BRD | Director/Board Member | 47 | 12/10/17 |
Sheng Xuan Jin
BRD | Director/Board Member | 48 | 25/05/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 401,743,872 | 156,631,424 ( 38.99 %) | 0 | 38.99 % |
Company contact information
Sichuan Goldstone Asia Pharmaceutical, Inc.
8/F, Area A1 Dadi New Guanghua Plaza
610072, Chengdu
+
http://www.goldstone-group.comSector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.19% | 415M | |
+20.76% | 43.77B | |
+28.00% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.70% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- 300434 Stock
- Company Sichuan Goldstone Asia Pharmaceutical Inc.